Published in J Virol on August 12, 2016
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med (2008) 4.57
Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med (2013) 4.09
Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut (2011) 3.71
Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol (2007) 3.71
Enteric bacteria promote human and mouse norovirus infection of B cells. Science (2014) 3.13
Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol (2003) 2.82
World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis. PLoS Med (2015) 2.35
Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol (2014) 2.31
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol (2005) 2.29
Recombination within the pandemic norovirus GII.4 lineage. J Virol (2013) 1.93
Norovirus GII.4 strain antigenic variation. J Virol (2010) 1.73
Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One (2008) 1.61
Low prevalence of rotavirus and high prevalence of norovirus in hospital and community wastewater after introduction of rotavirus vaccine in Nicaragua. PLoS One (2011) 1.55
Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology (2008) 1.54
Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol (2011) 1.53
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants. J Clin Virol (2012) 1.46
Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc (2012) 1.42
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J (2009) 1.39
Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. J Infect Dis (2013) 1.34
Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics (2007) 1.16
Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol (2013) 1.15
Evolution of norovirus. Clin Microbiol Infect (2014) 1.00
Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid. PLoS One (2013) 0.92
Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics. PLoS One (2014) 0.88
Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population. J Med Virol (2015) 0.84
Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol (2014) 0.81
Decline in gastroenteritis-related triage calls after rotavirus vaccine licensure. Pediatrics (2012) 0.79